Sun Pharmaceutical

Investors pummel Sun Pharma, shares tank 16% after profit warning

BSE Healthcare index emerge as the top sectoral loser, tumbling 3.6 percent to 17,255

Analytics ups the interest quotient in cricket, says Meheriar Patel from Sun Pharma

Meheriar Patel, Head Technology, Global Infrastructure at Sun Pharma, bats for analytics in sports and believes that data visualisation helps viewers understand the game better.

Sun Pharma stock up on US court's ruling

Sun Pharmaceutical Industries rose 2.4 percent after the US Supreme Court allowed the Indian drug maker to sue a brand name rival.

Indian drug makers see slowdown in US FDA approvals hitting sales for some time

India's $15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year.

Minor short term glitches: Indian pharma, Dalal St shouldn't worry about US inspections

Indian pharma companies and the investors need not worry about be the US inspections and price actions

Sun Pharma shells out $4 bn for Ranbaxy, becomes biggest Indian pharma firm

The merged company will become the world's fifth-largest specialty generics company and the largest drug firm in India.

Bitter pill for Sun Pharma, Sanofi wins US drug ruling

French drugmaker Sanofi has scored an important victory in a patent dispute with Sun Pharmaceuticals that will keep generic copies of its Eloxatin colon cancer drug off the United States market until August 2012.